J Am Acad Dermatol:皮肤镜能提高非色素性皮肤癌的诊断和管理

2017-09-27 MedSci MedSci原创

背景:无色素性皮肤癌(Nonpigmented skin cancer)是常见的,且用肉眼诊断时存在出错可能。皮肤镜又称皮表透光显微镜,皮肤镜学的英文名称和同义名包括Dermatoscope、Dermoscope、 Epiluminescence Microscope (ELM)、Incident light microscope、 Skin surface microscope。其功能和眼科用的

背景:无色素性皮肤癌(Nonpigmented skin cancer)是常见的,且用肉眼诊断时存在出错可能。皮肤镜又称皮表透光显微镜,皮肤镜学的英文名称和同义名包括Dermatoscope、Dermoscope、 Epiluminescence Microscope (ELM)、Incident light microscope、 Skin surface microscope。其功能和眼科用的眼底镜、耳鼻喉科用的耳镜一样,是用来观察皮肤色素性疾患的利器。最新一期的皮肤科档案杂志(Archive Dermatology)的研究亦显示,皮肤镜对恶性黑色素瘤诊断的专一性可以达到98%,甚至比临床诊断还要高。皮肤镜是一个相当方便、非侵入性、诊断率高、值得信赖的工具。目的:本研究旨在探讨皮肤镜检查是否能提高无色素(非黑色素)性皮肤肿瘤诊断的准确率。方法:研究人员收集了2072个良性和恶性的肿瘤病变的炎症情况,以及它们在特写镜头拍摄下的图片,这些图片使用/未使用皮肤镜时拍摄得到,并让95名经验不同的检验人员根据图片做出诊断。结果:与未使用皮肤镜拍摄的照片相比,使用皮肤镜的曲线图表中的曲线下面积

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1811010, encodeId=9afc1811010b8, content=<a href='/topic/show?id=3e2786e100c' target=_blank style='color:#2F92EE;'>#色素性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86710, encryptionId=3e2786e100c, topicName=色素性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Wed Oct 18 21:22:00 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737328, encodeId=a7511e3732892, content=<a href='/topic/show?id=cda39158eb5' target=_blank style='color:#2F92EE;'>#诊断和管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91587, encryptionId=cda39158eb5, topicName=诊断和管理)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=378a34283400, createdName=1249857fm43暂无昵称, createdTime=Mon Jun 25 00:22:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651888, encodeId=52c316518887a, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Thu Dec 14 20:22:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680448, encodeId=48e61680448aa, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Mon Dec 25 19:22:00 CST 2017, time=2017-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486647, encodeId=d48a148664e02, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Fri Sep 29 13:22:00 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
    2017-10-18 Homburg
  2. [GetPortalCommentsPageByObjectIdResponse(id=1811010, encodeId=9afc1811010b8, content=<a href='/topic/show?id=3e2786e100c' target=_blank style='color:#2F92EE;'>#色素性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86710, encryptionId=3e2786e100c, topicName=色素性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Wed Oct 18 21:22:00 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737328, encodeId=a7511e3732892, content=<a href='/topic/show?id=cda39158eb5' target=_blank style='color:#2F92EE;'>#诊断和管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91587, encryptionId=cda39158eb5, topicName=诊断和管理)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=378a34283400, createdName=1249857fm43暂无昵称, createdTime=Mon Jun 25 00:22:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651888, encodeId=52c316518887a, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Thu Dec 14 20:22:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680448, encodeId=48e61680448aa, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Mon Dec 25 19:22:00 CST 2017, time=2017-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486647, encodeId=d48a148664e02, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Fri Sep 29 13:22:00 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1811010, encodeId=9afc1811010b8, content=<a href='/topic/show?id=3e2786e100c' target=_blank style='color:#2F92EE;'>#色素性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86710, encryptionId=3e2786e100c, topicName=色素性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Wed Oct 18 21:22:00 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737328, encodeId=a7511e3732892, content=<a href='/topic/show?id=cda39158eb5' target=_blank style='color:#2F92EE;'>#诊断和管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91587, encryptionId=cda39158eb5, topicName=诊断和管理)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=378a34283400, createdName=1249857fm43暂无昵称, createdTime=Mon Jun 25 00:22:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651888, encodeId=52c316518887a, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Thu Dec 14 20:22:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680448, encodeId=48e61680448aa, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Mon Dec 25 19:22:00 CST 2017, time=2017-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486647, encodeId=d48a148664e02, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Fri Sep 29 13:22:00 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
    2017-12-14 lishizhe
  4. [GetPortalCommentsPageByObjectIdResponse(id=1811010, encodeId=9afc1811010b8, content=<a href='/topic/show?id=3e2786e100c' target=_blank style='color:#2F92EE;'>#色素性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86710, encryptionId=3e2786e100c, topicName=色素性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Wed Oct 18 21:22:00 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737328, encodeId=a7511e3732892, content=<a href='/topic/show?id=cda39158eb5' target=_blank style='color:#2F92EE;'>#诊断和管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91587, encryptionId=cda39158eb5, topicName=诊断和管理)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=378a34283400, createdName=1249857fm43暂无昵称, createdTime=Mon Jun 25 00:22:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651888, encodeId=52c316518887a, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Thu Dec 14 20:22:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680448, encodeId=48e61680448aa, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Mon Dec 25 19:22:00 CST 2017, time=2017-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486647, encodeId=d48a148664e02, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Fri Sep 29 13:22:00 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
    2017-12-25 sunylz
  5. [GetPortalCommentsPageByObjectIdResponse(id=1811010, encodeId=9afc1811010b8, content=<a href='/topic/show?id=3e2786e100c' target=_blank style='color:#2F92EE;'>#色素性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86710, encryptionId=3e2786e100c, topicName=色素性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Wed Oct 18 21:22:00 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737328, encodeId=a7511e3732892, content=<a href='/topic/show?id=cda39158eb5' target=_blank style='color:#2F92EE;'>#诊断和管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91587, encryptionId=cda39158eb5, topicName=诊断和管理)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=378a34283400, createdName=1249857fm43暂无昵称, createdTime=Mon Jun 25 00:22:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651888, encodeId=52c316518887a, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Thu Dec 14 20:22:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680448, encodeId=48e61680448aa, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Mon Dec 25 19:22:00 CST 2017, time=2017-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486647, encodeId=d48a148664e02, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Fri Sep 29 13:22:00 CST 2017, time=2017-09-29, status=1, ipAttribution=)]

相关资讯

Mayo Clin Proc:帕金森病与黑色素瘤竟然有瓜葛!

梅奥诊所研究发现,运动障碍帕金森病患者的皮肤癌黑色素瘤风险高得多,反之亦然。作者说,尽管需要进一步研究,但治疗一种疾病的医生应该警惕对方的迹象,并就这些患者的风险提供咨询。研究结果发表在Mayo Clinic Proceedings。

SCI REP:多吃西红柿可减少皮肤癌的发展

俄亥俄州立大学(Ohio State University)的一项动物实验研究表明,每日摄入番茄可以降低小鼠皮肤癌肿瘤的发展。《科学报告》杂志在线刊登了一项关于营养干预如何改变皮肤癌风险的新研究。研究发现,给雄性老鼠每天喂食10%的番茄粉,持续35周,然后将其曝露在紫外线下,与不吃脱水番茄的老鼠相比,实验组的皮肤癌肿瘤平均减少了50%。番茄和癌症之间的关系的理论解释是,膳食类胡萝卜素,赋予番茄颜色

J Am Acad Dermatol:临床医生需警惕——异体造血干细胞移植后,使用伏立康唑会增加皮肤鳞状细胞癌风险

既往的研究发现:皮肤癌是实体器官移植后最常见的恶性肿瘤,其中以皮肤鳞状细胞癌(SCC)最为常见,发生率为一般人群的65倍,患者的死亡风险亦增高52倍,随着移植后生存时间的延长其发病率逐渐增加。很多因素增加器官移植患者发生皮肤癌的危险性。近来,有多个对伏立康唑的应用与肺移植患者发生SCC的相关性报道。造血干细胞移植(HCT)患者常使用伏立康唑作为真菌感染的二级预防,但很少有研究探讨伏立康唑的使用对皮

Br J Dermatol:酒精摄入量与非黑素瘤皮肤癌的风险相关(Meta分析)

皮肤癌主要包括鳞状细胞癌、基底细胞癌、Bowen病、Paget病、恶性黑色素瘤五大类,以前两者为最多见。在美国,皮肤癌是最常见的癌症,而在我国,皮肤癌发病率较低,对治疗方法的探讨及认识相应较西方发达国家落后。近年来,随着皮肤癌发病率的上升,对该类疾病早期诊断和及时采取有效的的措施进行治疗越来越受到学术界的重视。非黑素瘤性皮肤癌(Nonmelanoma skin cancer,NMSC)主要包括基底

J Heal Commu:新发现,更方便地判断皮肤癌

经过一个夏天累积的晒伤,你会发现自己对肩膀上新发现的痣额外的偏执。所以你搜索“皮肤癌症的迹象”,并花了一个小时查看死亡统计数据并感到十分不安,然后更加不知所措。

惊恐!异常进食竟会导致皮肤晒伤甚至皮肤癌!

近日,美国西南医学中心的Peter O'Donnell Jr.脑研究所和加州大学欧文分校科学家通过小鼠试验表明,异常时间进食会破坏皮肤的生物钟,导致白天皮肤对紫外线的防御能力大幅下降。该研究对应文章则发表于最新上线的Cell Reports杂志。 尽管需要进一步研究加以证实这一结果,但这一发现仍在一定程度上表明深夜进食的人们可能更容易被紫外线晒伤或受到更为长期的消极影响,如加速皮肤老化或